Fig. 1: Clinical characteristics and efficacy of anti-PD-1 therapy in non-liver cancer patients with or without HBV infection. | Oncogenesis

Fig. 1: Clinical characteristics and efficacy of anti-PD-1 therapy in non-liver cancer patients with or without HBV infection.

From: Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer

Fig. 1

A HBV+ non-liver cancer patients and their HBV– counterparts were well matched for age, sex and cancer type. Each bar represents one patient’s information. Dashed line represents 65-year-old. B Forest plot of objective response rate (ORR) events. Odds ratio (OR) and p-value were calculated using Fisher’s exact test.

Back to article page